China Will Issue New Fast-Track Procedure For Drug Registration – CDE Official
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA will launch a new fast-track mechanism by year end called the special approval procedure for drug registration to accelerate drug registration, SFDA Center for Drug Evaluation Official Yi Feng, told China Trials 2008 attendees here Nov. 10